Last10K.com

Nighthawk Biosciences, Inc. (NHWK) SEC Filing 8-K Material Event for the period ending Friday, January 27, 2023

Nighthawk Biosciences, Inc.

HISTORY TOOLS
CIK: 1499543 Ticker: NHWK

View differences made from one to another to evaluate Nighthawk Biosciences, Inc.'s financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 8-K Corporate News to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Nighthawk Biosciences, Inc..

Continue

Assess how Nighthawk Biosciences, Inc.'s management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Nighthawk Biosciences, Inc.'s Definitive Proxy Statement (Form DEF 14A) filed after their 2023 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors

Continue

SEC Filing Tools

Financial Statements, Disclosures and Schedules

Inside this 8-K Corporate News

Cover
Ticker: NHWK
CIK: 1476963
Form Type: 8-K Corporate News
Accession Number: 0001553350-23-000064
Submitted to the SEC: Thu Feb 02 2023 4:05:14 PM EST
Accepted by the SEC: Thu Feb 02 2023
Period: Friday, January 27, 2023
Industry: Pharmaceutical Preparations
Events:
  1. Ending Agreement
  2. Financial Exhibit

External Resources:
Stock Quote
Social Media
SEC.gov

Bookmark the Permalink:
https://last10k.com/sec-filings/nhwk/0001553350-23-000064.htm